Ascites Market 2018; Perceive Accruals USD 2,832.5 Million | Market Boost by BioVie, Fresenius, Medtronic, etc. - Trends and Forecast to 2023

Market Research Future published reports related to the healthcare sector among others, recently forecasted in its report on Global Ascites Market Research Report- Forecast to 2023 that the market will demonstrate a steady CAGR of 4.0% while achieving million dollar growth readily in the forecast period.

Global Ascites Market – Overview:

Ascites is an abnormal accumulation of fluid in the abdominal cavity. Liver cirrhosis is the most common cause of ascites. Its presence is a sign of significant portal hypertension. Other less common factors that may contribute to ascites development are heart failure, kidney failure, cancers, and infection in pancreas.

Get Exclusive Sample Report @ https://www.marketresearchfuture.com/sample_request/1909

Ascites can be detected by physical examination at a volume greater than 1.5 ascites. For smaller amount of fluid ultrasound, and CT scan are preferred. Notably, rising prevalence of cirrhosis, improvement in reimbursement policies, and increasing occurrence of cancer are promoting the growth of ascites market globally. Rising prevalence of cirrhosis and its related complications directly promotes the growth of ascites market. Despite these drivers, complications associated with ascites treatment may hinder the growth of market.

Ascites Market - Key Players         

Some of key the players in the ascites market are Sequana Medical, BioVie, PharmaCyte Biotech Inc., Fresenius SE & Co. KGaA, BD, GI Supply, Medtronic plc, and others.

Ascites Market - Key Findings

The global ascites market is expected to reach USD 3710.4 million by 2023 at a CAGR of 4.0%.

On the basis of the diagnosis, the ultrasound segment is expected to command the largest market share of 9% over the review period and it is also expected to grow at the fastest CAGR of 4.4% during the forecast period 2017-2023

On the basis of the type, exudate ascites is expected to command the largest market share of 55.8% over the review period and it is also expected to grow at the fastest CAGR of 4.4% during the forecast period 2017-2023

The Americas hold the largest share of the global ascites market and is expected to reach USD 1,292.2 million by 2023

Asia Pacific is the fastest growing market, which is expected to grow at a CAGR of 4.5% over the 2017-2023 

Ascites Market - Segmentation

The global ascites market is segmented on the basis of type, diagnosis, treatment, and end user.

On the basis of the type, the market is classified into transudative ascites, and exudate ascites.

On the basis of the treatment, the market is segmented into surgeries and others. The surgeries segment is further sub-segmented into peritoneovenous shunting, liver transplantation, transjugular intrahepatic portosystemic shunt (TIPS), and other surgeries.

On the basis of the end -users, the market is segmented into hospital, and clinics, ambulatory surgical centers, diagnostic centers, and others.

Get Your Customized Report @ https://www.marketresearchfuture.com/reports/ascites-market-1909

Ascites Market - Regional Analysis

The Americas dominate the ascites market owing to the well-developed technology, high healthcare expenditure, rising prevalence of cirrhosis, and the presence of the leading players in the region. According to the data suggested by the Centers for Disease Control and Prevention in 2015, around 1.6 % adults have been diagnosed with the chronic liver disease in the United States i.e. 3.9 million. It is also stated that from 2000 to 2015 death rates due to the chronic liver disease and cirrhosis was increased by 31% in the United States among individuals aged 45–64 years.

Asia Pacific region is projected to be the fastest growing region during the forecast period. Rapidly improving technology and the presence of huge patient pool drive the growth of this market in Asia Pacific region.

The Middle East and Africa hold the least share of the ascites market owing to the presence of poor and slow developing countries, especially, in African region.

Global Ascites Market - Competitive Analysis:

Characterized by the presence of several well-established and small players, the global market of Ascites appears to be highly competitive and fragmented. With well-established market in the North America region major companies have their home in the region and generate maximum market share.

Under this agreement, Fresenius Medical Care acquired the rights to distribute the alfapump system across various regions such as Europe, Middle East and Africa markets. These distribution are not currently serviced by Sequana Medical’s in these region.

Major Table of Content:

1 REPORT PROLOGUE

2 MARKET INTRODUCTION

2.1 Research Objective 15

2.2 Assumptions & Limitations 15

2.2.1 Assumptions 15

2.2.2 Limitations 15

2.3 Market Structure 16

3 RESEARCH METHODOLOGY

3.1 Introduction 17

3.1.1 Primary Research Methodology 18

3.1.2 Secondary Research Methodology 19

3.1.3 Market Share Analysis 20

3.1.4 Trade Analysis 20

3.1.5 Market Pricing Approach 21

4 MARKET DYNAMICS

4.1 Introduction 22         

4.2 Drivers 23

4.2.1 Rising Prevalence Of Cirrhosis (Impact Weightage: 35%) 23

4.2.2 Improvement In Reimbursement Policies (Impact Weightage: 30%) 24

4.2.3 Increasing Occurrence Of Cancer (Impact Weightage: 35%) 25

TOC Continued…!

Get Discount @ https://www.marketresearchfuture.com/check-discount/1909

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.